Uses: ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is a balloon device to facilitate weight loss in obese adult patients with a body mass index (BMI) of 30 to 40 kg/m2.
Delivery: The device works by occupying space in the stomach, which may trigger feelings of fullness, or by other mechanisms that are not yet understood. It is delivered into the stomach via the mouth through a minimally invasive endoscopic procedure. Once in place, the balloon device is inflated with a sterile solution.
More Information: The approval was based on a clinical study involving 326 obese participants aged 22 to 60 years who had at least 1 obesity-related health condition. In the study, 187 individuals randomly selected to receive the device lost an average of 14 lbs. when the device was removed at 6 months while the control group lost an average of 7 lbs.
Side Effects/Risks: Potential side effects for the procedure include headache, muscle pain, and nausea from the sedation and procedure. Once the device is placed in the stomach, patients may experience vomiting, nausea, abdominal pain, gastric ulcers, and indigestion. The device should not be used in patients who have had previous gastrointestinal or bariatric surgery or who have been diagnosed with inflammatory intestinal or bowel disease, large hiatal hernia, symptoms of delayed gastric emptying or active H. Pylori infection, those who are pregnant or use aspirin daily.
Source: FDA web site. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455103.htm. Updated July 16, 2015. Accessed August 3, 2015.
This Week's Must Reads
HCV and Increased Risk of Atherosclerosis, Hepatol Int; ePub 2018 Feb 8; Bridge, et al
Chronic HCV & Early HIV Viral Response to ART, AIDS; ePub 2018 Jan 13; Willis, Cole, et al
Impact of DM/HBV Coinfection in Patients with HCV, J Gastroenterol Hepatol; ePub 2018 Jan 26; Subramaniam, et al
Prevalence of HCV and Route of Transmission, J Viral Hepat; 2018 Feb; Wong, Lee, Ng, et al
Liver Fibrosis & Microbial Translocation in HIV/HCV, J Infect Dis; ePub 2018 Jan 3; Reid, et al
Must Reads in Obesity
Bariatric Surgery and All-Cause Mortality, JAMA; 2018 Jan 16; Reges, Greenland, et al
Fiber Supplementation and Metabolic Outcomes, Am J Clin Nutr; 2017 Dec; Thompson, et al
Risk of Obesity From Childhood into Adulthood, N Engl J Med; 2017 Nov 30; Ward, Long, et al
Weight Loss Diets & All-Cause Mortality, BMJ; ePub 2017 Nov 14; Ma, Avenell, et al
Cancer Risk in Overweight & Obese Individuals, MMWR; ePub 2017 Oct 3; Steele, et al